Home | Business News | Browse by Publication | P | Pharma Marketletter

Zentiva to buy Sicomed, Romania's largest generics group, for $200M.

Publication: Pharma Marketletter
Publication Date: 26-SEP-05
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Czech Republic-headquartered Zentiva NV says it has signed an agreement to acquire 51% of S C Sicomed SA, the number one generic drugmaker in Romania, for a consideration of $102.0 million in cash. The purchase will be made through the acquisition of Venoma Holdings, which currently owns this 51% stake.

Zentiva also intends to launch a voluntary tender offer for the remaining 49% of Sicomed's shares at a price of $0.4997 each, representing a 37% premium to the firm's average closing price for the one-month period ended September...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Neurochem launches Ph III European Alzhemed trial.(Brief Article), September 26, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.